13F Holdings
中文EN

CCM Concord Medical Services Holdings Ltd Annual reports only

Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1472072 · Reporting currency CNY

Financial factors as of 2018-12-31 (FY2018), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-42.3%
TTM net income YoY17.4%
TTM EPS YoY-26.0%
Revenue 3-yr CAGR-32.3%
Net income 3-yr CAGR—

Margins

Gross margin10.4%
Operating margin-156.8%
Net margin-123.0%
FCF margin-107.0%
EBITDA margin-135.4%

Returns

ROE-34.3%
ROA-5.8%
ROIC (approx.)-28.0%
Asset turnover0.05x

Leverage & solvency

Liabilities / assets50.4%
Debt / equity2.14x
Current ratio1.41x
Interest coverage-6.47x

Cash quality & payout

Operating cash flow / net income0.16x
Accruals ratio-4.9%
Payout ratio—
Capex / revenue86.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31 · CNYFY20242024-12-31 · USDFY20232023-12-31 · CNYFY20222022-12-31 · CNYFY20212021-12-31 · USD
Income statement
Revenue460.51M$52.60M537.40M472.08M$76.21M
Cost of revenue434.69M$63.45M614.01M624.49M$85.14M
Gross profit25.82M-$10.85M-76.61M-152.41M-$8.93M
SG&A expense212.97M$55.40M330.08M311.16M$54.57M
Operating income-261.49M-$72.91M-462.99M-525.05M-$71.92M
Interest expense152.33M$26.47M165.67M120.36M$11.58M
Pretax income-373.36M-$91.73M-555.59M-839.90M$83.05M
Income tax6.06M-$2.40M-24.57M-70.91M-$1.03M
Net income-92.81M-$42.23M-297.66M-489.66M-$42.59M
EBITDA-157.98M-$61.29M-380.86M-436.36M-$61.83M
EPS (basic)-0.71-0.32-2.27-3.74-0.98
EPS (diluted)-0.71-0.32-2.27-3.74-0.98
Weighted avg. shares (diluted)131.05M131.05M131.05M131.05M131.05M
Banking
Loans, net———294.13M$26.56M
Balance sheet
Cash & equivalents297.79M$33.89M58.14M159.34M$23.04M
Short-term investments1,000$18.44M———
Receivables44.05M$7.01M73.50M130.27M$20.07M
Inventory45.97M$4.58M40.35M84.83M$5.98M
Current assets941.91M$134.80M617.21M759.80M$91.72M
PP&E, net3.72B$507.49M3.55B3.26B$493.52M
Goodwill572.22M$81.83M575.43M575.43M$84.36M
Intangibles255.91M$40.02M323.29M353.77M$103.23M
Total assets6.55B$921.51M6.05B6.00B$977.62M
Current liabilities1.95B$291.17M1.95B1.12B$126.25M
Short-term debt981.06M$141.48M1.04B512.58M$46.97M
Long-term debt2.47B$369.03M1.99B2.47B$341.87M
Total debt3.45B$510.51M3.04B2.98B$388.84M
Total liabilities4.70B$699.88M4.31B3.99B$547.07M
Shareholders' equity-2.10B-$312.41M-2.12B-1.86B-$215.00M
Net debt3.15B$476.62M2.98B2.82B$365.80M
Cash flow statement
Operating cash flow-201.82M-$54.49M-276.47M-216.69M-$56.39M
Capital expenditure56.32M$20.66M113.00M222.98M$43.78M
Free cash flow-258.15M-$75.15M-389.47M-439.67M-$100.17M
Investing cash flow53.97M-$81.30M-47.68M-118.79M-$88.81M
Financing cash flow197.23M$157.00M257.65M383.09M$100.81M
Depreciation & amortization103.51M$11.61M82.12M88.69M$10.09M
Stock-based compensation——0-5.92M$2.30M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.